Back to search

University of Ioannina

Αξιολόγηση συμμόρφωσης ασθενών με χρόνια αποφρακτική πνευμονοπάθεια στη θεραπεία: φαρμακευτική - οξυγονοθεραπεία

Abstract

dc:description

Long-term oxygen therapy (LTOT) is the only therapeutic modality proven to alter the late course of chronic obstructive pulmonary disease (COPD). In particular, patients with chronic hypoxaemia (resting PaO₂ level<55mmHg in room air) under steady disease state as well as those hypoxaemic patients (resting PaO₂:56-59mmHg) in the presence of cor pulmonale and/or polycythemia require LTOT administration. It is widely known that LTOT improves survival rates in these patients if oxygen is received for at least 15h/day, as it exerts beneficial effects on several pulmonary haemodynamic variables (pulmonary artery pressure, right and left ventricular function, haematocrit, mixed venous PaO₂). Two different oxygen administration systems have been developed for LTOT: concentrators and liquid oxygen, which have actually eliminated high-pressure compressed gas cylinders, present in the early years of LTOT implementation. Several studies have been conducted in different European countries, concerning patients under LTOT and its influence on compliance rate, exercise capacity and quality of life as primary outcome measures for survival. Greece is one of the countries where the issue of LTOT is poorly investigated. Our study is divided into two phases. The aim of the first phase was to investigate the compliance of patients under LTOT in the Prefecture of Ioannina (North-Western Greece) and to identify factors that might affect it. The study included 249 patients under LTOT during one year period. They were visited at home by the investigating staff (a chest specialist and a primary care nurse). Compliance to therapy was defined by the daily duration of the O₂ concentrator use (hours). Patients underwent pulse oximetry, basic spirometry, and trial inhalation of bronchodilators. The results were as follows: Only 67 patients (26.9%) complied with therapy, while the daily concentrator use lasted for 9.7 ± 6.09 hours. SaO₂, FEV₁ and FVC were negatively correlated to patients’ compliance. No significant differences concerning LTOT compliance were noted between men and women, urban and rural population, and between smokers, ex-smokers and non-smokers. A chest physician recommended LTOT for the majority of patients (86.3%), while COPD was the main reason for LTOT prescription (74.7%). Nevertheless, compliance to LTOT was not significantly higher, when prescribed by a respiratory physician. No specific medical instructions and information was recorded for the majority of the examined patients, under LTOT. In conclusion, LTOT overuse and the concomitant poor compliance to therapy is a strong message indicating further investigation to all links included (medical and nursing staff, concentrator dealers and, of course, patients). The relative results and conclusions would reinforce any attempt to settle a national LTOT policy. An organized home-care program for COPD patients is the cornerstone of a positive patients’ attitude regarding LTOT thus improving its efficacy. The aim of the second phase was to investigate the effect of two oxygen sources (concentrator and liquid oxygen) on quality of life, exercise tolerance and compliance to LTOT in patients with COPD. The survey included 104 patients with COPD (31 on concentrator treatment and 73 on liquid). Patients were subjected to pulse oximetry, basic spirometry, measurement of health-related quality of life by the St. George’s Hospital Respiratory Questionnaire instrument (SGRQ) and assessment of dyspnea severity by the modified Borg category scale. Exercise tolerance was evaluated by the SaO₂ value after 3 minutes walking. SaO₂ was measured before and after treatment with each device. Compliance with therapy was defined by the daily duration of oxygen use. The results were the following: The two LTOT groups did not differ significantly concerning PFTs (p=0.49 for FEV₁, 0.98 for FVC, 0.15 for FEV₁/FVC% and 0.38 for FEF₅₀), SaO₂ before (p=0.28), after (p=0.80) O₂ treatment and after the 3 min walking trial (p=0.47) and SGRQ score (p=0.45). The liquid oxygen group was less dyspneic before treatment (p=0.02) but this difference disappeared after treatment (p=0.95). A highly significant difference (p<0.001) was noted concerning the daily oxygen use. Complete compliance to LTOT (≥ 15 h/day) was observed in 12.9% and 42.5% respectively (p<0.005). Noise disturbance was noted only in the concentrator group (80%). In conclusion, stationary liquid oxygen seems to be a satisfactory alternative mode for LTOT treatment in COPD patients, with higher patients’ compliance to therapy in comparison with concentrators.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Katsenos, Stamatis
  • Κατσένος, Σταμάτης

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/20599

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Katsenos, Stamatis; Κατσένος, Σταμάτης. Αξιολόγηση συμμόρφωσης ασθενών με χρόνια αποφρακτική πνευμονοπάθεια στη θεραπεία: φαρμακευτική - οξυγονοθεραπεία. University of Ioannina, 2007. http://hdl.handle.net/10442/hedi/20599